« Previous
Next »
Titles
- CBO’s Medicaid baseline forecast1
- CDC found ways to use data to understand and address COVID-19 health disparities, despite challenges with existing data1
- CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios1
- CMS should bolster its oversight of manufacturer-submitted average sales price data to ensure accurate Part B drug payments1
- CMS should take further action to address states with poor performance in conducting nursing home surveys1
- COVID-19 antivirals utilization: geographic and demographic patterns of treatment in 20221
- COVID-19 cases and deaths, metropolitan and nonmetropolitan counties over time: (update)1
- COVID-19 in nursing homes: CMS needs to continue to strengthen oversight of infection prevention and control : report to congressional addressees1
- COVID-19 public health emergency: policy on COVID-19-related sanitation tunnels : guidance for industry and investigators1
- COVID-19 relief bolstered U.S. child care programs in crisis1
- COVID-19: Current and future federal preparedness requires fixes to improve health data and address improper payments : report to congressional committees1
- COVID-19: FDA took steps to help make tests available; policy for future public health emergencies needed : report to congressional addressees1
- COVID-19: Federal efforts to provide vaccines to racial and ethnic groups : report to congressional committees1
- COVID-19: HHS and DOD transitioned vaccine responsibilities to HHS, but need to address outstanding issues : report to congressional addressees1
- COVID-19: Information on HHS's public education campaign : report to congressional committees1
- COVID-19: Pandemic lessons highlight need for public health situational awareness network : report to congressional addressees1
- Cancer clinical trial eligibility criteria: available therapy in non-curative settings1
- Center for Devices and Radiological Health (CDRH) appeals processes: Guidance for industry and Food and Drug Administration staff1
- Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic1
- Certain ophthalmic products: policy regarding compliance with 21 CFR part 41